EGFR and lung adenocarcinoma: Therefore, 142 EGFR mutations in exon 19 were chosen from approximately 601 cases of lung adenocarcinoma, and the finding that the scoring system about the distinction in EGFR mutation subtypes could be helpful and useful for selection of suitable clinical treatments.